日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Development of a fully human anti-PDGFRbeta antibody that suppresses growth of human tumor xenografts and enhances antitumor activity of an anti-VEGFR2 antibody

开发完全人源抗 PDGFRbeta 抗体,以抑制人类肿瘤异种移植瘤的生长并增强抗 VEGFR2 抗体的抗肿瘤活性

Juqun Shen, Marie Danielle Vil, Marie Prewett, Chris Damoci, Haifan Zhang, Huiling Li, Xenia Jimenez, Dhanvanthri S Deevi, Michelle Iacolina, Anthony Kayas, Rajiv Bassi, Kris Persaud, Anna Rohoza-Asandi, Paul Balderes, Nick Loizos, Dale L Ludwig, James Tonra, Larry Witte, Zhenping Zhu